Rosen Law Firm reminds Hims & Hers investors of the November 2 lead plaintiff deadline in the securities class action. The lawsuit alleges the company misled investors about sharing health data with third-party ad platforms and charging for prescriptions immediately after intake. The stock fell 14.7% on July 29 after the FTC announced a related complaint.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
